Las Vegas April 11, 2008 -- Collaborating with the life science industry's efforts to more effectively implement and use electronic data capture (EDC) software for clinical trials, TrialStat Corporation, the industry's first clinical data solutions on demand company, will participate in a panel discussion of experts at the 12th Annual EDC and Beyond Conference.

Taking place on April 15, the panel will discuss The Industry-Wide Adoption of EDC. Peter O'Blenis, Vice President Product Management, will provide an EDC vendor perspective for the panel session and will be joined by representatives from the Harvard Clinical Research Institute, Schering-Plough Research Institute and Takeda Global Research & Development.

The two-day conference examines EDC implementation and management issues and trends. The conference is co-located with the 17th Annual Partnerships with CROs conference located at the Mandalay Bay Resort and Casino.

As a SaaS or on demand EDC solution, TrialStat's ClinicalAnalytics 4.0™ (CA 4.0) enables organizations to deploy their studies twice as fast as the industry average, which reduces the time and cost associated with drug development. CA 4.0 provides contract research organizations and biopharma organizations with an innovative EDC platform that enables the rapid deployment and management of clinical trials regardless of phase and therapeutic area. TrialStat will demonstrate CA 4.0 at booth 431.

Details of the panel discussion are:

Who: Peter O'Blenis, Vice President Product Management

When: April 15 at 11:30a.m. (Pacific Time)

Where: Mandalay Bay Resort and Casino,

What: The Industry-Wide Adoption of EDC

For media inquiries, please contact:
Muay Lim
TrialStat Corporation
613-741-9909 ext 153
mlim @ trialstat.com

ClinicalAnalytics 4.0 is a registered trademark of TrialStat Corporation.